Trials / Completed
CompletedNCT00740168
Bevacizumab Treatment and Retinal Vessel Monitoring
Analysis of Retinal Vessel Reaction and Monitoring of Circulation Parameters During Bevacizumab Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Technische Universität Dresden · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Bevacizumab might influence the dynamic vessel function after being administered intravenously.
Detailed description
By monitoring different vessel and circulation parameters (e.g. dynamic retinal vessel analyzer) the study will clarify the potential hemodynamic effects of bevacizumab.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bevacizumab treatment | single infusion 10 mg/kg |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2008-12-01
- Completion
- 2009-04-01
- First posted
- 2008-08-22
- Last updated
- 2016-01-21
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00740168. Inclusion in this directory is not an endorsement.